{"title":"Central obesity increases the risk of breast cancer irrespective of menopausal status in women: Systematic review and meta-analysis","authors":"Aboma Motuma , Ibsa Mussa , Alemayehu Deressa , Lemma Demissie Regassa , Abdi Birhanu","doi":"10.1016/j.ctarc.2025.100965","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>The incidence of breast cancer increased over the last few decades, however, it is less known about the relationship between central obesity and breast cancer incidence irrespective menopause. Given the increase in the incidence of breast cancer during the past decades, several studies have investigated the effects of variables body mass index on breast cancer, especially obesity. However, this meta-analysis aims to address the relationship between central obesity and risk of pre and postmenopausal breast cancer regardless of the age.</div></div><div><h3>Method</h3><div>A full electronic search of the Cochrane Library, Scopus, Web of Science, Excerpta Medicine Database (Embase), PubMed, Google Scholar, MESH Medline, and Cancer Literature databases was conducted from 2016 to 2023. The study followed the PRISMA Statement for Systematic Reviews and Meta-analyses protocol. The relevant cohort and case-control studies were screened by two reviewers independently. The data were extracted using Microsoft Excel and analyzed using STATA version 17. Publication bias was detected using a funnel plot, with a p value <0.05 indicate potential publication bias. The I<sup>2</sup> test was used to assess the heterogeneity of the studies. The overall estimates with a 95 % confidence interval were estimated using a random effect model analysis.</div></div><div><h3>Results</h3><div>A total of eight studies with 135,876 women participants were included in this study. The heterogeneity of the studies I<sup>2</sup> test was 87.1 %. The overall pooled results, women who presented with central obesity was 2.4 times more likely to develop breast cancer than those who had no history of central obesity (AOR=2.4, 95 % CI; 1.35–4.27).</div></div><div><h3>Conclusion</h3><div>This study revealed that central obesity is a risk factor of breast cancer. Interventions should be implement to reduce progression of breast cancer through lifestyle change. This study emphasises the need for breast cancer screening and treatment in individuals with central obesity.</div></div>","PeriodicalId":9507,"journal":{"name":"Cancer treatment and research communications","volume":"44 ","pages":"Article 100965"},"PeriodicalIF":2.4000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer treatment and research communications","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2468294225001017","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Background
The incidence of breast cancer increased over the last few decades, however, it is less known about the relationship between central obesity and breast cancer incidence irrespective menopause. Given the increase in the incidence of breast cancer during the past decades, several studies have investigated the effects of variables body mass index on breast cancer, especially obesity. However, this meta-analysis aims to address the relationship between central obesity and risk of pre and postmenopausal breast cancer regardless of the age.
Method
A full electronic search of the Cochrane Library, Scopus, Web of Science, Excerpta Medicine Database (Embase), PubMed, Google Scholar, MESH Medline, and Cancer Literature databases was conducted from 2016 to 2023. The study followed the PRISMA Statement for Systematic Reviews and Meta-analyses protocol. The relevant cohort and case-control studies were screened by two reviewers independently. The data were extracted using Microsoft Excel and analyzed using STATA version 17. Publication bias was detected using a funnel plot, with a p value <0.05 indicate potential publication bias. The I2 test was used to assess the heterogeneity of the studies. The overall estimates with a 95 % confidence interval were estimated using a random effect model analysis.
Results
A total of eight studies with 135,876 women participants were included in this study. The heterogeneity of the studies I2 test was 87.1 %. The overall pooled results, women who presented with central obesity was 2.4 times more likely to develop breast cancer than those who had no history of central obesity (AOR=2.4, 95 % CI; 1.35–4.27).
Conclusion
This study revealed that central obesity is a risk factor of breast cancer. Interventions should be implement to reduce progression of breast cancer through lifestyle change. This study emphasises the need for breast cancer screening and treatment in individuals with central obesity.
期刊介绍:
Cancer Treatment and Research Communications is an international peer-reviewed publication dedicated to providing comprehensive basic, translational, and clinical oncology research. The journal is devoted to articles on detection, diagnosis, prevention, policy, and treatment of cancer and provides a global forum for the nurturing and development of future generations of oncology scientists. Cancer Treatment and Research Communications publishes comprehensive reviews and original studies describing various aspects of basic through clinical research of all tumor types. The journal also accepts clinical studies in oncology, with an emphasis on prospective early phase clinical trials. Specific areas of interest include basic, translational, and clinical research and mechanistic approaches; cancer biology; molecular carcinogenesis; genetics and genomics; stem cell and developmental biology; immunology; molecular and cellular oncology; systems biology; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; cancer policy; and integration of various approaches. Our mission is to be the premier source of relevant information through promoting excellence in research and facilitating the timely translation of that science to health care and clinical practice.